Literature DB >> 22266752

MicroRNAs in control of cardiac hypertrophy.

Paula A Da Costa Martins1, Leon J De Windt.   

Abstract

MicroRNAs refer to a subfamily of small non-coding RNA species that are designed to influence gene expression in nearly all cell types studied to date. Studies from the past decade have demonstrated that microRNAs are atypically expressed in the cardiovascular system under specific pathological conditions. Gain- and loss-of-function studies using in vitro and in vivo models have revealed distinct roles for specific microRNAs in cardiovascular development, physiological functions, and cardiac pathological conditions. In this review, the current relevant findings on the role of microRNAs in cardiac hypertrophic growth are updated, the target genes of these microRNAs are summarized, and the future of microRNAs as potential therapeutic targets is discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266752     DOI: 10.1093/cvr/cvs013

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  69 in total

Review 1.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

2.  Identification of novel circulatory microRNA signatures linked to patients with ischemic stroke.

Authors:  Murali Vijayan; Subodh Kumar; Xiangling Yin; Dila Zafer; Vishal Chanana; Pelin Cengiz; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

3.  Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.

Authors:  Yi-Hui Yu; Zuo-Ying Hu; Ming-Hui Li; Bing Li; Zhi-Mei Wang; Shao-Liang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 4.  Transcriptome complexity in cardiac development and diseases--an expanding universe between genome and phenome.

Authors:  Chen Gao; Yibin Wang
Journal:  Circ J       Date:  2014-04-22       Impact factor: 2.993

Review 5.  Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs.

Authors:  Tiago Fernandes; Valério G Baraúna; Carlos E Negrão; M Ian Phillips; Edilamar M Oliveira
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

Review 6.  The Role of MicroRNAs in the Cardiac Response to Exercise.

Authors:  Xiaojun Liu; Colin Platt; Anthony Rosenzweig
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 7.  MicroRNAs: pleiotropic players in congenital heart disease and regeneration.

Authors:  Sarah C Hoelscher; Stefanie A Doppler; Martina Dreßen; Harald Lahm; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 8.  Missing links in cardiology: long non-coding RNAs enter the arena.

Authors:  Tim Peters; Blanche Schroen
Journal:  Pflugers Arch       Date:  2014-03-13       Impact factor: 3.657

Review 9.  MicroRNA: A new therapeutic strategy for cardiovascular diseases.

Authors:  Saheli Samanta; Sathyamoorthy Balasubramanian; Sheeja Rajasingh; Urmi Patel; Anuradha Dhanasekaran; Buddhadeb Dawn; Johnson Rajasingh
Journal:  Trends Cardiovasc Med       Date:  2016-03-03       Impact factor: 6.677

10.  Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension.

Authors:  J E Kontaraki; M E Marketou; E A Zacharis; F I Parthenakis; P E Vardas
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.